로딩 중…
지수 로딩 중…
Maze Therapeutics, Inc.
MAZE· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$25.68+3.38%
2026-06-18
Price Chart
Maze Therapeutics, Inc.+128.06%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.42B |
| Revenue | $20M |
| Net Income | $-123M |
| Total Assets | $420M |
| Net Assets | $342M |
| Value | |
| P/B | 4.16x |
| P/S | 71.06x |
| FCF Yield | -8.59% |
| Profitability | |
| ROE | -35.86% |
| ROA | -29.20% |
| Op. Margin | -670.25% |
| Revenue Growth | -100.00% |
| Earnings Growth | -351.04% |
| Financial Health | |
| Debt Ratio | 22.83% |
| Total Debt | $61M |
| FCF | $-122M |
| Cash | $199M |
| Current Ratio | 17.88x |
| Performance | |
| 1Y Return | 128.06% |
| 1M Return | 4.99% |
| From 52W High | -52.13% |
| 1Y MDD | -54.51% |
| Trading | |
| Volume | 1,045,809 shares |
| Trading Value | $27M |
| Per Share | |
| EPS | $-3.05 |
| BPS | $8.26 |